Plasma Exosomal AKR1C3 mRNA Expression Is a Predictive and Prognostic Biomarker in Patients with Metastatic Castration-Resistant Prostate Cancer.

Sha ZhuYuchao NiZilin WangXingming ZhangYaowen ZhangFengnian ZhaoJindong DaiZhipeng WangXudong ZhuJunru ChenJinge ZhaoYuhao ZengNi ChenPeng ZengPengfei ShenGuangxi SunHao Zeng

Published in: The oncologist (2022)

AKR1C3-EXO is associated with patient prognosis regarding OS and ABI-PFS and can be used as a biomarker in mCRPC.

Keyphrases

case report